Arthur Schopenhauer wrote: "All truth passes through 3 stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident."

LONDON - The virus that causes cold sores may also lead to something far worse: Alzheimer's disease.

A new study - published Monday in the Journal of Pathology - links the herpes simplex virus to the devastating disease that affects 20 million people worldwide.

Researchers at the University of Manchester found that 90% of the protein plaques in Alzheimer's sufferers' brains contain the virus. Protein plaques are a key abnormality in the brains of those afflicted.

Ruth Itzhaki, who has been investigating the disease for 18 years, said her team believes the herpes simplex virus 1 is a "major" cause of the disease. But she cautioned that "there's no evidence that people who get cold sores are going to get Alzheimer's. " It's also necessary to have a specific genetic variant that makes people vulnerable, she said.

Itzhaki said the research suggests that anti-viral medicine such as acyclovir - currently used to treat cold sores - could be an effective treatment for Alzheimer's.

"It would stop what we think is a major cause, rather than stopping symptoms only" as current treatments do, she said.

Most people carry the herpes simplex virus, which remains in the nervous system for their entire lives, and 20% to 40% of carriers get cold sores. The Manchester team believes the virus enters the brains of the elderly as their immune systems decline and establishes a silent infection which is activated by stress or other infections.

Alzheimer's organizations reacted cautiously to the study.

"This could lead to new treatments for Alzheimer's based on existing anti-viral agents," said Rebecca Wood of the Alzheimer's Research Trust.

But she added that "the underlying causes of Alzheimer's disease are still unknown."

The Atlantic Monthly (Feb '99) has an interesting cover article on the 'New Germ Theory' being suggested by Darwinian scientists. The premise, with some supporting evidence, is that many of the killer/troubling diseases like heart disease, Multiple Sclerosis, and Alzheimers are in good part due to bacterial and viral infections. A few early studies, for example, have found higher antibodies to a specific bacteria in heart disease patients, and HHV-6 virus is a suspect in MS cases. They discuss how remote nations will have zero cases of MS, then suddenly the incidence of this disease explodes, suggesting an infectious pathogen as the cause.

Check out the Bakken Library and Museum at the following web address: This museum specializes in the history of electricity and magnetism in medical treatment, etc. The Bakken Library and Museum is a center for education and learning that furthers the understanding of the history, cultural context, and applications of electricity and magnetism in the life sciences and medicine. Located in a Tudor mansion in suburban Minneapolis, it holds a unique collection of 10,000 rare books and 2,000 scientific instruments relating to the historical role of 'electricity in life.'

More evidence that cancer can be caused by a microbe:
A report by researchers at the Technical University of Dresden Germany was about a transplant recipient who died of cancer after receiving a liver from a donor who had brain cancer. The donor was a 47-year-old who died after developing glioblastoma multiforme, an incurable, lethal form of brain tumor. An autopsy performed soon after the patient's death revealed no apparent sign of cancer spread. The patient's liver was subsequently transplanted into the body of a 29-year-old recipient. The researchers say the recipient developed cancers at various sites (including the brain) soon after the transplant, and died about 5 months later. After conducting DNA and laboratory testing, the investigators concluded that all of the recipient's cancers were 'donor-related.' The report "justifies caution with and further investigation of the use of patients with brain tumors as organ donors," conclude Drs. Patrick Healey and Connie Davis of the University of Washington Medical Center in Seattle.

Jan. 7 1999 -- Jacobson Resonance Enterprises announced today a year-long study performed at Cornell University Medical College has demonstrated that sciatic nerves of mice exposed to the Jacobson Resonator's low-level magnetic fields resulted in nerve growth and regeneration including the myelin sheath. Click here to read the whole story. This is fantastic news! I suspect the output of this device is a continual frequency output of an oscillating bipolar magnetic field, unlike the Beck Pulser which occassionally gives out one uni-polar quick powerful pulse of magnetic field strength. (It sounds more like our Multi-Pulser except that it's continuous in output.)

A private research group reported this about Beck style Magnetic Pulsers: The results from using the Beck Pulser on trauma-type injuries, acute sprains and certain types of facial neuralgia---were nothing short of astounding. Some severe ankle sprains responded with total pain reduction within as little as 1.5 hours. DMSO, (70%) topically applied, greatly accelerated local pain reduction. Rapid swelling reduction occurred in 95% of all cases and bruise-site discoloring was markedly reduced.......sometimes within 4 to 5 hours.
  Some, intractably painful facial neuralgia (dentally-related) conditions were relieved within 4 to 5 hours. Some of these cases had experienced continual, excruciating, pain for up to 14 days prior to this protocol. The most dramatic pain abatement occurred when the magnetic pulser was used in conjunction with the administration of 400mg of bone meal tablets every 2-3 hours, followed by 20 minutes continual exposure (at 1.5 sec repetition rate) to the magnetic pulser. No more than 1600 mg of bone meal was ever administered during a 24 hour period. The longest time required for a complete positive response in these neuralgia EXPERIMENTS, was 48 hours.
  No untoward side-effects were ever experienced by any of the volunteers----regardless of the magnetic field intensity employed (up to 5 times the strength of the original Beck Pulser).

Cancer reversal by oscillating magnetic fields: Dr Alejandro Torres emailed me: "In lab test performed here at the UABC (University of Baja California) we were unable to kill cancer cells or some bacteria in a petri dish using Jaguars Multi-Pulsers, but really curious, those machines worked pretty nice on live subjects. We used Cancer markers to test this and almost all the patients showed a dramatic decrease in titers (meaning the cancer cell activity is decreasing), and in one patient it fell from 245 to almost zero. But the most important thing, the patients start feeling better and more energetic (some patients restarted sexual activity, very notable in older patients). One patient who had multiple cancer growths throughout her body is doing so much better that she's now back at work."

Cancer Personality: Back in 1927 Elida Evans, a student of Carl Jung, documented a link between depression and cancer in a study almost totally neglected in the intervening years. In a long-term project begun in 1946 by Dr. Caroline Bedell Thomas at John Hopkins School of Medicine, students were given personality tests, and the occurrence of disease among them was charted over several decades. In this and later studies, a high risk of developing cancer has been correlated with a specific psychological profile that includes a poor relationship with parents, self-pity, self-deprecation, passivity, a compulsive need to please, and above all an inability to rise from depression after some traumatic event such as the death of a loved one or loss of a job. In such a person, cancer typically follows the loss in a year or two. Several physicians have found they can greatly increase cancer patients’ chances of a cure with biofeedback, meditation, hypnosis, or visualization techniques."

About a month ago I saw on CNN Headline News that doctors in California found a bacteria that causes plaque in arteries which of course contributes to heart attacks, strokes, hardening of the arteries, reduced circulation, etc. One more reason everyone should do a month of blood electrification every year.

'Protected' H.I.V. 11-11-99 WASHINGTON (Reuters) - Scientists had more bad news for HIV patients on Thursday, saying they found that, within days of infecting someone, the virus manages to find hiding places that no drug currently in use is able to reach. The finding is another setback to doctors who had hoped that perhaps HIV could be stopped early, either with quick drug treatment or by somehow stimulating the body's immune system. Microbiologist Ashley Haase of the University of Minnesota and colleagues said that within 3 days of getting into the body, the virus sneaks into cells known as resting T-cells. These cells are good hiding places because they are inactive and thus not noticed by the immune system. Nor can they be targeted by drugs, which need some kind of activity by the virus or the cells it infects in order to work. At least half the cells infected early on were resting T-cells, Haase said. "This study identifies a source of cells that are invulnerable to current therapies," Haase said. In addition, most vaccine techniques need activated T-cells to work. Dr. Anthony Fauci, head of the National Institute of Allergies and Infectious Diseases (NIAID), said the study helped explain why people who took strong cocktails of drugs for years were not cured. "We have shown that you can whittle down the latent reservoir to virtually undetectable levels, but as soon as we stop the drugs, 2 1/2 weeks later, boom -- the virus came right back," he said in a telephone interview. This suggested the virus was hiding. [To read the full article go to ]

From "This paper deals with a completely different method of weight removal and drugless, pain control, which has been devised as a result of recent medical discoveries and for which I have invented a suitable electrotheraputic modality capable of generating unique interferential, sub-microcurrent pulse waves"

Researchers reporting online in the Proceedings of the National Academy of Sciences think prostate cancer may be related to avirus. Scientists at Columbia University and the University of Utah have determined that a virus that's already known to cause certain other cancers in animals is present in human prostate cancer cells.

Bioelectromagnetics. 2000 Jul;21(5):395-401.
Experimental low-level direct current therapy in liver metastases: influence of polarity and current dose.
Turler A, Schaefer H, Schaefer N, Wagner M, Maintz D, Qiao JC, Hoelscher AH.

Department of Visceral- and Vascular Surgery, University of Cologne, Germany.

Several authors recently reported on the successful local treatment of malignant disease with low-level direct current therapy. However, antitumoral effects in colorectal metastases has not been investigated experimentally. The aim of the present study was to assess the effectiveness of this therapy and the influence of polarity and current dose. Colorectal metastases were established in BD IX rats by the injection of colon cancer cells under the liver capsule. After three weeks, the liver tumor volumes were determined by magnetic resonance imaging of the liver. Low-level direct current therapy was applied via five platinum electrodes. Four different applications were used: 60 C/cm(3), anode at the center; 60 C/cm(3), cathode at the center; 80 C/cm(3), anode at the center; and 80 C/cm(3), cathode at the center. In the control group, five electrodes were placed without applying any direct current. All animals were sacrificed on postoperative day 7. Liver metastases were histologically examined for vital tumor cells. Statistical analysis was performed with chi(2)-test. The mean initial tumor diameter before treatment was 3.6 +/- 1.4 mm (volume: 25.2 +/- 9.7 mm(3)). Histological examination of the removed livers revealed significant destruction of the metastases with localized necroses in all treatment groups; 37% had a complete response rate and 63% a partial response rate. There were no significant necroses in the control group (P < 0.0001). The best treatment results were obtained in the group with an anode at the center and a current dose of 80 C/cm(3). Direct current therapy offers a new and safe method for the local treatment of liver metastases. We were able to observe that tumor damage is related to current dose but not to the polarity of the central electrode.


Scand J Gastroenterol. 2000 Mar;35(3):322-8.
Local treatment of hepatic metastases with low-level direct electric current: experimental results.
Turler A, Schaefer H, Schaefer N, Maintz D, Wagner M, Qiao JC, Hoelscher AH.

Dept. of Visceral and Vascular Surgery, University of Cologne, Germany.

BACKGROUND: Several authors have recently reported encouraging results from low-level direct current therapy in easily accessible malignant tumors. However, antitumoral effects in colorectal metastases have not been investigated experimentally. METHODS: Using an animal model with induced hepatic metastases, we analyzed the effectiveness and the tumor growth dynamics after direct current application. Three weeks after induction tumor volumes were estimated with magnetic resonance imaging (MRI). Then direct current (80 C/cm3) was applied in the treatment group by means of one anode in the tumor center and four cathodes peripherally. In the control group electrodes were placed without applying current. Tumor growth dynamics was analyzed with MRI after 3 and 5 weeks. After this all animals were killed, and the livers histologically examined. RESULTS: After 5 weeks MRI showed a 1.6-fold tumor enlargement in the treatment group versus a 2.9-fold enlargement in the control group (Student t test, P=0.0051). The histopathologic analysis of the treated livers yielded a 21% complete response rate and a 78% partial response rate. No necroses were found in the control group. CONCLUSIONS: These results confirm the effectiveness of low-level direct current application as a potential modality for the treatment of hepatic metastases.


Br J Surg. 1998 Sep;85(9):1212-6.
Experimental study of electrolysis-induced hepatic necrosis.
Robertson GS, Wemyss-Holden SA, Dennison AR, Hall PM, Baxter P, Maddern GJ.

University of Adelaide, Department of Surgery, The Queen Elizabeth Hospital, South Australia, Australia.

BACKGROUND: One of the most promising but unexplored methods for treating patients with irresectable liver tumours is electrolysis. This study examined the effect of increasing 'current dose' on the volume of the lesion induced in normal rat liver. METHODS: A direct current generator, connected to platinum electrodes implanted in the rat liver, was used to examine the effect of (1) varying current doses from 1 to 5 coulombs and (2) electrode separation (2 or 20 mm), on the volume of liver necrosis. RESULTS: There was a significant correlation (P < 0.001) between the current dose and the volume of necrosis produced for each electrode separation. Placing the electrodes 2 mm apart resulted in smaller total volumes of necrosis than placing them 20 mm apart when anode lesions were significantly larger than cathode lesions (P< 0.05). Liver enzymes (aspartate aminotransferase, alanine aminotransferase) were significantly raised 1 day after treatment (P < 0.001) and predicted the total volume of hepatic necrosis (P < 0.001). CONCLUSION: Predictable and reproducible areas of liver necrosis are produced with electrolysis. If these results extrapolate to larger animal models, this technique has potential for patients with irresectable primary and secondary liver tumours.

Vic hospital trials new cancer treatment

Mon Nov 24 2008
By Katie Bradford

Radiologists say Irreversible Electroporation (IRE) has the potential to provide an alternative to surgery or radiotherapy.
The technique involves using a device called an IRE-Nanoknife to accurately place fine needle electrodes in or around the tumour, which is then targeted with short intense electric pulses.
Ken Thomson, The Alfred's Professor of Radiology, said the technique is "remarkable" and could very possibly replace chemotherapy in the future.
"We're on the way to proving the safety of it," Dr Thomson said.
"But we haven't really got a technique that we can say guarantees this would be as good as surgery. We're some months or years away from that point."
He is confident about its potential, but refused to go as far as to call it a cure for cancer.
"I'm trying to stay calm, I'm extremely excited about it because I think it has enormous potential, but I don't want to raise false hopes among the public that I've suddenly got a cure that no one else has."
The treatment creates microscopic holes in the wall of the tumour cells, causing the cells to die before they are removed by the body.
Seventeen prostate cancer patients have been treated in America using the technique, which gave Dr Thomson the confidence it would work in Australia.
So far he has treated a liver cancer patient and one with kidney cancer.
What surprised Dr Thomson was how painless the procedure was, with patients reporting no negative effects after undergoing the treatment.
There are many more positives.
"It's very quick, it doesn't appear to cause any damage to the surrounding tissue, the tissue appears to grow back normally without blocking arteries and veins and (IRE) appears to have a wide ability to treat a solid tumour, and no pain afterwards, there's very little bad about it," he said.
IRE also is very low risk, with needles placed on the tumour in 40-second bursts.
"I think personally it's a breakthrough because of the lack of surrounding damage."
The nerves, blood vessels and tissues have all come out unscathed in patients treated during trials.
Tumours start shrinking almost straight away and are half the size in just two weeks.